Follow US:
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
A program to test a smartphone-based COVID-19 exposure notification system will expand to an additional five University of California campus locations, including UC Riverside, as a result of success from an initial deployment earlier this fall at two UC campuses. The program is a joint effort between the UCs and...
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
As the fall quarter begins, UC Riverside has a new diagnostic lab operating on campus that will rapidly process samples from students and employees as part of an ongoing coronavirus testing program. The lab, located at the Multidisciplinary Research Building, or MRB, tested its first sample in August and opened...
Telehealth visits can be conducted on a cell phone, tablet, or pad device, allowing even individuals without a computer or internet to be seen by a UCR Health physician
